IVI RMA North America, a leader in assisted reproductive technologies with over 22 IVF laboratories across the U.S. and Canada, has partnered with Gaia, the first provider of value-based family building, to make fertility treatment more accessible through outcome-focused care.
The partnership combines IVI RMA’s clinical expertise and success rates with Gaia’s value-based financial model, allowing patients on fixed budgets to access multiple cycles of fertility treatment with financial protection. The collaboration offers patients flexible payment options, including the ability to pay upfront, monthly, or only after successful outcomes.
“This collaboration with Gaia exemplifies our unwavering commitment to putting patients first – both by delivering industry leading outcomes for individuals and couples navigating infertility in the U.S., and by making the cost of treatment more accessible and flexible,” said Lynn Mason, CEO of IVI RMA North America. “Collaborating with Gaia will allow us to further expand our reach and offer new opportunities to those seeking our care.”
Through the partnership, patients will receive access to IVI RMA’s medical expertise alongside Gaia’s wraparound care model, which includes personal concierge services, counseling sessions, and community events. The approach shifts the focus from providing treatments to achieving successful outcomes, regardless of patients’ financial, employment, or relationship status.
“We believe in making fertility treatment possible for everyone and giving them the opportunity to pay for what they truly want—results,” said Nader AlSalim, founder and CEO of Gaia. “It’s exciting to partner with IVI RMA North America, a leading reproductive medicine group with the industry’s best outcomes, the most innovative research and development, and the sharpest talent—and amazing results.”
IVI RMA North America, which comprises Reproductive Medicine Associates, Boston IVF, and Toronto-based TRIO, has supported the births of over 220,000 babies to date. The network has published over 1,000 research papers and pioneered innovations including PGT-A, single embryo transfer, and fertility preservation.
Gaia operates as a value-based family building company that takes on financial risk so patients only pay for successful outcomes. The company offers access to a vetted network of clinics selected for their results, with flexible payment options and comprehensive support services.
The partnership aims to make fertility treatment accessible to anyone seeking to build a family, whether through immediate IVF treatment or future planning via egg and embryo freezing, while providing enhanced support throughout the process.
